Back to results
Key Publications June 8, 2017

Statins, ezetimibe, and proprotein convertase subtilisin-kexin type 9 inhibitors to reduce low-density lipoprotein cholesterol and cardiovascular events.

Am J Cardiol. 2017;119:565-571

O'Keefe JH, DiNicolantonio JJ, Lavie CJ

Back to results